Cisco warns of pharma malware threat; Celgene invests in Venter's Human Longevity;

> Cisco found pharma was one of the industries most exposed to malware in the first half of 2014. Article

> Celgene ($CELG) invested in J. Craig Venter's Human Longevity as part of a partnership deal. News

> Certara added suggested synthesis steps to its drug candidate design software. Release

> Huron Consulting began offering a clinical trial data analytics and visualization service. Item

> An academic analyzed the threats posed by possible breaches of biological databases. Feature